drugset / Trial / NCT00911339
Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the extent of the mobilization of endothelial progenitor cells induced by low versus high dose atorvastatin after 4 weeks of treatment, in patients treated with anti-CD 34 antibodies coated stent.
Timeline
- Start
- 2009-01
- Primary completion
- 2021-05-13
- Completion
- 2021-05-13
Outcome
Outcome not reported
Stopped: “prematurely interrupted because of difficulty in enrolment of patients.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 10 mg | — |
| Comparator | Atorvastatin | Small molecule | 80 mg | — |